195 related articles for article (PubMed ID: 36675246)
1. Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol.
Vidoni C; Ferraresi A; Vallino L; Salwa A; Ha JH; Seca C; Garavaglia B; Dhanasekaran DN; Isidoro C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675246
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy.
Ferraresi A; Esposito A; Girone C; Vallino L; Salwa A; Ghezzi I; Thongchot S; Vidoni C; Dhanasekaran DN; Isidoro C
Cells; 2021 Nov; 10(11):. PubMed ID: 34831435
[No Abstract] [Full Text] [Related]
3. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
Ferraresi A; Phadngam S; Morani F; Galetto A; Alabiso O; Chiorino G; Isidoro C
Mol Carcinog; 2017 Mar; 56(3):1164-1181. PubMed ID: 27787915
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
[TBL] [Abstract][Full Text] [Related]
9. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2).
Jiao L; Zhang HL; Li DD; Yang KL; Tang J; Li X; Ji J; Yu Y; Wu RY; Ravichandran S; Liu JJ; Feng GK; Chen MS; Zeng YX; Deng R; Zhu XF
Autophagy; 2018; 14(4):671-684. PubMed ID: 28980855
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
[TBL] [Abstract][Full Text] [Related]
13. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract][Full Text] [Related]
14. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
15. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.
Avena P; Anselmo W; Whitaker-Menezes D; Wang C; Pestell RG; Lamb RS; Hulit J; Casaburi I; Andò S; Martinez-Outschoorn UE; Lisanti MP; Sotgia F
Cell Cycle; 2013 May; 12(9):1360-70. PubMed ID: 23574724
[TBL] [Abstract][Full Text] [Related]
16. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
19. Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.
Ornelas A; McCullough CR; Lu Z; Zacharias NM; Kelderhouse LE; Gray J; Yang H; Engel BJ; Wang Y; Mao W; Sutton MN; Bhattacharya PK; Bast RC; Millward SW
BMC Cancer; 2016 Oct; 16(1):824. PubMed ID: 27784287
[TBL] [Abstract][Full Text] [Related]
20. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
